4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-19-009482
COO and Secretary sold 7,500 shares at an average $19.08 ($143,089)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuth Alexander O. COO and Secretary | 2019-02-08 | Sale | −2,500 | $18.11 | $45,275 | 667,589 | I |
| Schuth Alexander O. COO and Secretary | 2019-02-11 | Sale | −1,234 | $18.74 | $23,125 | 666,355 | I |
| Schuth Alexander O. COO and Secretary | 2019-02-11 | Sale | −1,266 | $19.35 | $24,497 | 665,089 | I |
| Schuth Alexander O. COO and Secretary | 2019-02-12 | Sale | −800 | $19.73 | $15,784 | 664,289 | I |
| Schuth Alexander O. COO and Secretary | 2019-02-12 | Sale | −1,700 | $20.24 | $34,408 | 662,589 | I |
| Open-market sales · 7,500 sh · avg $19.08 · $143,089 | |||||||
Loading xslF345X03/doc4.xml…